China’s biotechs are faster and have lower costs, and its drug research threatens to soon overtake the West’s ...

It is unclear how many employees are stationed at the company's 181 Oyster Point Blvd. facility, but all will transition to ...

The GLP-1 agonist at the center of Pfizer’s upfront $4.9 billion buyout of Metsera last week has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability,” ...

In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug ...

One of the world’s largest biotech companies is closing its only office in the Bay Area. Pfizer is shutting down its office ...

The news is the latest example of the biotech industry's struggles in the Bay Area.

Pharmaceutical companies AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, ...

COPENHAGEN (Reuters) -Denmark's Novo Nordisk launched a rival bid for U.S. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer as drugmakers jostle for advantage in the ...

Learn how pharma company Pfizer makes money through prescription drugs, vaccines, oncology treatments, and global ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Pfizer-backed biotech landed ...

Biotech companies Valneva and Pfizer announced results from the Phase three trial of a Lyme disease vaccine candidate that ...

The choice is based on more than just the dividend payout.